Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1983 2
1984 4
1985 1
1986 4
1987 2
1988 2
1989 6
1990 3
1991 5
1992 12
1993 9
1994 8
1995 6
1996 6
1997 6
1998 8
1999 6
2000 5
2001 2
2002 7
2003 5
2004 8
2005 5
2006 15
2007 8
2008 9
2009 17
2010 7
2011 13
2012 10
2013 11
2014 18
2015 28
2016 28
2017 14
2018 35
2019 25
2020 33
2021 42
2022 35
2023 22
2024 5

Text availability

Article attribute

Article type

Publication date

Search Results

454 results

Results by year

Filters applied: . Clear all
Page 1
The frequency of low HER2 expression in breast cancer and a comparison of prognosis between patients with HER2-low and HER2-negative breast cancer by HR status.
Horisawa N, Adachi Y, Takatsuka D, Nozawa K, Endo Y, Ozaki Y, Sugino K, Kataoka A, Kotani H, Yoshimura A, Hattori M, Sawaki M, Iwata H. Horisawa N, et al. Among authors: sugino k. Breast Cancer. 2022 Mar;29(2):234-241. doi: 10.1007/s12282-021-01303-3. Epub 2021 Oct 7. Breast Cancer. 2022. PMID: 34622383
Adult Thyroid Outcomes of Congenital Hypothyroidism.
Sugisawa C, Narumi S, Tanase-Nakao K, Hoshiyama A, Suzuki N, Ohye H, Fukushita M, Matsumoto M, Yoshihara A, Watanabe N, Sugino K, Hishinuma A, Noh JY, Katoh R, Taniyama M, Ito K. Sugisawa C, et al. Among authors: sugino k. Thyroid. 2023 May;33(5):556-565. doi: 10.1089/thy.2022.0481. Epub 2023 Apr 21. Thyroid. 2023. PMID: 36792927
Clinical management of low-risk papillary thyroid microcarcinoma.
Masaki C, Sugino K, Ito K. Masaki C, et al. Among authors: sugino k. Minerva Endocrinol (Torino). 2021 Dec;46(4):413-427. doi: 10.23736/S2724-6507.20.03283-6. Epub 2021 Jan 12. Minerva Endocrinol (Torino). 2021. PMID: 33435642 Review.
Japanese guideline for the treatment of idiopathic pulmonary fibrosis.
Homma S, Bando M, Azuma A, Sakamoto S, Sugino K, Ishii Y, Izumi S, Inase N, Inoue Y, Ebina M, Ogura T, Kishi K, Kishaba T, Kido T, Gemma A, Goto Y, Sasaki S, Johkoh T, Suda T, Takahashi K, Takahashi H, Taguchi Y, Date H, Taniguchi H, Nakayama T, Nishioka Y, Hasegawa Y, Hattori N, Fukuoka J, Miyamoto A, Mukae H, Yokoyama A, Yoshino I, Watanabe K; Ministry of Health, Labour and Welfare, the Study Group on Diffuse Pulmonary Disorders, Scientific Research/Research on Intractable Diseases, and Japanese Respiratory Society. Homma S, et al. Among authors: sugino k. Respir Investig. 2018 Jul;56(4):268-291. doi: 10.1016/j.resinv.2018.03.003. Epub 2018 Jul 3. Respir Investig. 2018. PMID: 29980444 Review.
Miliary opacities in pulmonary sarcoidosis.
Sugino K, Ono H, Ando M, Igarashi S, Kurosaki A, Tsuboi E. Sugino K, et al. Respirol Case Rep. 2020 Apr 18;8(5):e00563. doi: 10.1002/rcr2.563. eCollection 2020 Jul. Respirol Case Rep. 2020. PMID: 32313657 Free PMC article.
Amyloid tumor of the breast.
Mori M, Kotani H, Sawaki M, Hattori M, Yoshimura A, Gondo N, Adachi Y, Kataoka A, Sugino K, Horisawa N, Terada M, Ozaki Y, Iwata H. Mori M, et al. Among authors: sugino k. Surg Case Rep. 2019 Feb 19;5(1):31. doi: 10.1186/s40792-019-0591-z. Surg Case Rep. 2019. PMID: 30783867 Free PMC article.
Phase II study of the efficacy and safety of lenvatinib for anaplastic thyroid cancer (HOPE).
Higashiyama T, Sugino K, Hara H, Ito KI, Nakashima N, Onoda N, Tori M, Katoh H, Kiyota N, Ota I, Suganuma N, Hibi Y, Nemoto T, Takahashi S, Yane K, Ioji T, Kojima S, Kaneda H, Sugitani I, Tahara M. Higashiyama T, et al. Among authors: sugino k. Eur J Cancer. 2022 Sep;173:210-218. doi: 10.1016/j.ejca.2022.06.044. Epub 2022 Aug 3. Eur J Cancer. 2022. PMID: 35932627 Clinical Trial.
Intraoperative Integrated Diagnostic System for Malignant Central Nervous System Tumors.
Hayashi T, Tateishi K, Matsuyama S, Iwashita H, Miyake Y, Oshima A, Honma H, Sasame J, Takabayashi K, Sugino K, Hirata E, Udaka N, Matsushita Y, Kato I, Hayashi H, Nakamura T, Ikegaya N, Takayama Y, Sonoda M, Oka C, Sato M, Isoda M, Kato M, Uchiyama K, Tanaka T, Muramatsu T, Miyake S, Suzuki R, Takadera M, Tatezuki J, Ayabe J, Suenaga J, Matsunaga S, Miyahara K, Manaka H, Murata H, Yokoyama T, Tanaka Y, Shuto T, Ichimura K, Kato S, Yamanaka S, Cahill DP, Fujii S, Shankar GM, Yamamoto T. Hayashi T, et al. Among authors: sugino k. Clin Cancer Res. 2024 Jan 5;30(1):116-126. doi: 10.1158/1078-0432.CCR-23-1660. Clin Cancer Res. 2024. PMID: 37851071
Genetic alterations that deregulate RB and PDGFRA signaling pathways drive tumor progression in IDH2-mutant astrocytoma.
Tateishi K, Miyake Y, Nakamura T, Iwashita H, Hayashi T, Oshima A, Honma H, Hayashi H, Sugino K, Kato M, Satomi K, Fujii S, Komori T, Yamamoto T, Cahill DP, Wakimoto H. Tateishi K, et al. Among authors: sugino k. Acta Neuropathol Commun. 2023 Nov 27;11(1):186. doi: 10.1186/s40478-023-01683-x. Acta Neuropathol Commun. 2023. PMID: 38012788 Free PMC article.
454 results